These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31902192)

  • 1. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries.
    Oortwijn W; van Oosterhout S; Kapiriri L
    Int J Technol Assess Health Care; 2020 Jul; ():1-5. PubMed ID: 32715993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Gopinathan U; Ottersen T; Cyr PR; Chalkidou K
    Int J Health Policy Manag; 2021 Mar; 10(4):232-236. PubMed ID: 32772012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2022 Oct; 11(10):2327-2336. PubMed ID: 34923809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
    Baltussen R; Jansen M; Oortwijn W
    Int J Health Policy Manag; 2022 Oct; 11(10):2319-2326. PubMed ID: 34923808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
    Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
    Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective.
    Kapiriri L; Baltussen R; Oortwijn W
    Int J Technol Assess Health Care; 2020; 36(1):29-33. PubMed ID: 31944173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Schlander M
    Int J Health Policy Manag; 2021 Mar; 10(3):158-161. PubMed ID: 32610783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient advocate perspectives on involvement in HTA: an international snapshot.
    Scott AM; Wale JL;
    Res Involv Engagem; 2017; 3():2. PubMed ID: 29062527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstrating the influence of HTA: INAHTA member stories of HTA impact.
    Werkö SS; Merlin T; Lambert LJ; Fennessy P; Galán AP; Schuller T
    Int J Technol Assess Health Care; 2020 Nov; 37():e8. PubMed ID: 33148373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
    Oortwijn W; Klein P
    Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INSIGHTS FROM THE FRONT LINES: A COLLECTION OF STORIES OF HTA IMPACT FROM INAHTA MEMBER AGENCIES.
    Schuller T; Söderholm Werkö S
    Int J Technol Assess Health Care; 2017 Jan; 33(4):409-410. PubMed ID: 29241477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'Top 10' Challenges for Health Technology Assessment: INAHTA Viewpoint.
    O'Rourke B; Werkö SS; Merlin T; Huang LY; Schuller T
    Int J Technol Assess Health Care; 2020; 36(1):1-4. PubMed ID: 31775943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines.
    Grigore B; Ciani O; Dams F; Federici C; de Groot S; Möllenkamp M; Rabbe S; Shatrov K; Zemplenyi A; Taylor RS
    Pharmacoeconomics; 2020 Oct; 38(10):1055-1070. PubMed ID: 32572825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topic selection process in health technology assessment agencies around the world: a systematic review.
    Qiu Y; Thokala P; Dixon S; Marchand R; Xiao Y
    Int J Technol Assess Health Care; 2022 Feb; 38(1):e19. PubMed ID: 35129112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
    Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
    Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Goetghebeur M; Cellier M
    Int J Health Policy Manag; 2021 Mar; 10(4):228-231. PubMed ID: 32610794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
    Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
    Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.